1Life Healthcare Inc. (NASDAQ:ONEM) does about 2.64M shares in volume on a normal day but saw 1501487 shares change hands in Monday trading. The company now has a market cap of 3.27B USD. Its current market price is $16.21, marking a decrease of -0.98% compared to the previous close of $16.37. The 52 week high reached by this stock is $17.55 whilst the lowest price level in 52 weeks is $5.94. The script in recent trading has seen the stock touch a high of $16.43 and a low of $16.21.
Top 5 Undervalued Stocks To Own In 2023
Microchip Maker Releases "World's Most Powerful Data Center CPU". It could allow the company who manufactures it to lead the industry as the global microchip shortage continues into the coming year. We've put together a free research report that explains all the details. Not only will you find out why analysts believe this chip manufacturer could lead the pack, you will also discover four more potential winners for the coming year.
Click here to download your Free Research Report…
Sponsored
1Life Healthcare Inc. (ONEM) has a 20-day trading average at $16.50 and the current price is -7.64% off the 52-week high compared with 172.90% distance from its 52-week low. The 50-day simple moving average of the closing price is $16.67 and its 200-day simple moving average is $13.98. If we look at the stock’s price movements over the week, volatility stands at 1.34%, which decreases to 1.16% over 1 month. It is also key to look at other market indicators of price movement for the stock, where we see that the relative strength index (RSI) is at 37.87 to suggest the stock is neutral.
The consensus objective for the share price is $18.18, suggesting that the stock has a potential upside of 10.84% over the period.
The company shares received a number of brokerage firm price updates over the past month, with the latest being on July 12, 2022 when Deutsche Bank downgraded the stock to “Hold” and issued a price target of between $11 and $12. Evercore ISI also downgraded the stock to “In-line” from Outperform on July 11, 2022 at a price target of $11-$12. BTIG Research upgraded its price target at $15.
The current price level is -1.94%, -2.86%, and 16.14% away from its SMA20, SMA50, and SMA200 respectively, with the ONEM price moving above the 50-day SMA on January 23. 1Life Healthcare Inc. (ONEM) stock is down -1.28% over the week and -3.57% over the past month. Its price is -2.99% year-to-date and 44.35% over the past year.
The stock last released its quarterly earnings report for quarter ended 9/29/2022, with the company’s earnings per share (EPS) of -$0.57 below consensus estimates by -$0.11. The company’s next earnings report is expected on 05/03/2023, with forecasts estimating quarterly EPS at -$0.53 and -$2.04 for whole year. ONEM’s earnings per share are forecast to shrink by -24.40% this year and 8.80% over next year. Expected sales for next quarter are $318.24 million, which analysts say will come at $1.04 billion for the current fiscal year and next year at $1.32 billion. In addition, estimates put the company’s current quarterly revenue at an average of $275.15 million.
To reach the target analysts have set, the stock logically needs to grow 10.84 percent from here.
Outstanding shares total 195.62M with insiders holding 1.98% of the shares and institutional holders owning 79.92% of the company’s common stock. The company has a return on investment of -11.90% and return on equity of -23.80%. Price to book ratio is 2.04 and price to sales ratio is 3.27.
According to a U.S. Securities and Exchange Commission filing, Vanguard Total Stock Market Index has added its position in 1Life Healthcare Inc. (ONEM) to 5,580,123 shares, mirroring a recent increase by 5.36%. Vanguard Total Stock Market Index added 0.28 million shares of 1Life Healthcare Inc. common stock bringing its total worth to about $93.24 million at the end of recent close, SEC documents show. Vanguard Total Stock Market Index isn’t the only investment manager who changed stakes and is followed by Vanguard Small Cap Index Fund, which added 0.19 million shares to end up with 4,738,922 shares worth $79.19 million.
